Biomarin Pharmaceutical Inc. - Registered Shares

NASDAQ:BMRN   3:59:59 PM EDT
84.51
-1.49 (-1.73%)
Products, Strategic Combinations

Biomarin And Skyline Therapeutics Announce Strategic Collaboration

Published: 12/16/2021 21:21 GMT
Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) - Biomarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases.
Biomarin Pharmaceutical Inc - Skyline Therapeutics and Co to Collaborate on Discovery and Research Through to an Investigational New Drug Application.
Biomarin Pharmaceutical Inc - Skyline Therapeutics Will Receive an Undisclosed Payment Associated With Signing From Biomarin.
Biomarin Pharmaceutical Inc - Skyline Therapeutics Will Be Eligible to Receive Royalty Payments on Future Sales From Biomarin in Its Territories.